Histone Deacetylase (HDAC) Inhibitors: A Fruitful Lead for Medicinal
Chemists in the Discovery of Novel Drug(s) for Various Health Disorders

Dilipkumar      Pal

doi:10.2174/138945012409230720102737

[1]
Pal D, Lal P. Tropolones and thailandepsin B as lead-like natural compounds in the development of potent and selective histone deacetylase inhibitors. Curr Drug Targets  2023; 24: 698-717.

[2]
Tiwari V, Banerjee SK. Therapeutic potential of HDAC inhibitors in the treatment of cardiac diseases: A short review. Curr Drug Targets  2023; 24: 718-27.

[3]
Pal D, Sahu P, Mishra A, Hagelgans A, Sukocheva O. Histone deacetylase inhibitors as cognitive enhancers and modifiers of mood and behavior. Curr Drug Targets  2023; 24: 728-50.

Rights & Permissions Print Cite

Current Drug Targets

Title:Histone Deacetylase (HDAC) Inhibitors: A Fruitful Lead for Medicinal Chemists in the Discovery of Novel Drug(s) for Various Health Disorders

Volume: 24 Issue: 9

Author(s): Dilipkumar Pal

Affiliation:

Export Options

Export File:

RIS (for EndNote, Reference Manager, ProCite)

BibTeX

Text

Content:

Citation Only

Citation and Abstract

About this article

Cite this article as:

Pal Dilipkumar, Histone Deacetylase (HDAC) Inhibitors: A Fruitful Lead for Medicinal Chemists in the Discovery of Novel Drug(s) for Various Health Disorders, Current Drug Targets 2023; 24 (9) . https://dx.doi.org/10.2174/138945012409230720102737

DOI https://dx.doi.org/10.2174/138945012409230720102737	Print ISSN 1389-4501
Publisher Name Bentham Science Publisher	Online ISSN 1873-5592